AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
METRONIDAZOLE USP
7 registrations across 3 African markets— 1 active
Markets with METRONIDAZOLE USP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Flazole injection Solution for Injection | 🇿🇲Zambia | Cipla Ltd | active | Dec 2029 |
| DORMETRO INJECTION 1 X 100ML | 🇳🇬Nigeria | DORGLORY PHARM LTD 32 | expired | Mar 2022 |
| METRONIDAZO LE INJECTION 1 X 100ML | 🇳🇬Nigeria | CORNEBE PHARMACEUTICALS LTD 157 | expired | Mar 2022 |
| TRIMETRO IV INFUSION INFUSION / 1X100ML | 🇳🇬Nigeria | TAH PHARMACEUTICALS LTD 38 | expired | Aug 2021 |
| GG METRONIDAZO LE INJECTION INJECTION/1X100ML | 🇳🇬Nigeria | GENEITH PHARMA LTD 14A | expired | Apr 2021 |
| METROGYL 500MG/100ML INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2016 |
| METRON-IV 5MG/ML INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2013 |
METRONIDAZOLE USP in Africa — Regulatory Overview
METRONIDAZOLE USP is registered across 3 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Nigeria, Malawi, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 1 (14%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.